[go: up one dir, main page]

MX2012004560A - Compuestos de quinuclidina como ligandos del receptor de acetilcolina nicotinico alfa-7. - Google Patents

Compuestos de quinuclidina como ligandos del receptor de acetilcolina nicotinico alfa-7.

Info

Publication number
MX2012004560A
MX2012004560A MX2012004560A MX2012004560A MX2012004560A MX 2012004560 A MX2012004560 A MX 2012004560A MX 2012004560 A MX2012004560 A MX 2012004560A MX 2012004560 A MX2012004560 A MX 2012004560A MX 2012004560 A MX2012004560 A MX 2012004560A
Authority
MX
Mexico
Prior art keywords
alpha
acetylcholine receptor
receptor ligands
nicotinic acetylcholine
compounds
Prior art date
Application number
MX2012004560A
Other languages
English (en)
Inventor
John E Macor
Dalton King
Richard E Olson
James H Ii Cook
Ivar M Mcdonald
Nenghui Wang
F Christopher Zusi
Christiana I Iwuagwu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX2012004560A publication Critical patent/MX2012004560A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención proporciona compuestos de la fórmula (Ver Formula) incluyendo sus sales, así como composiciones y métodos para usar los compuestos. Los compuestos son ligandos para el receptor nicotínico 7 y pueden ser útiles para el tratamiento de varios trastornos del sistema nervioso central, especialmente trastornos afectivos y neurodegenerativos.
MX2012004560A 2009-10-29 2009-10-29 Compuestos de quinuclidina como ligandos del receptor de acetilcolina nicotinico alfa-7. MX2012004560A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/062492 WO2011053292A1 (en) 2009-10-29 2009-10-29 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands

Publications (1)

Publication Number Publication Date
MX2012004560A true MX2012004560A (es) 2012-05-08

Family

ID=41361291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004560A MX2012004560A (es) 2009-10-29 2009-10-29 Compuestos de quinuclidina como ligandos del receptor de acetilcolina nicotinico alfa-7.

Country Status (14)

Country Link
EP (1) EP2493892B1 (es)
JP (1) JP5619907B2 (es)
KR (1) KR20120099060A (es)
CN (1) CN102791718B (es)
AU (1) AU2009354790A1 (es)
BR (1) BR112012010054A2 (es)
CA (1) CA2779177C (es)
EA (1) EA201270610A1 (es)
ES (1) ES2544970T3 (es)
IL (1) IL219366A0 (es)
MX (1) MX2012004560A (es)
NZ (1) NZ600240A (es)
TN (1) TN2012000191A1 (es)
WO (1) WO2011053292A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ608069A (en) 2010-10-06 2014-06-27 Glaxosmithkline Llc Benzimidazole derivatives as pi3 kinase inhibitors
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
CA3128846C (en) * 2012-07-27 2025-05-06 Sato Pharmaceutical Co. Ltd. COMPOSITE OF DIFLUOROMETHYLENE
WO2016073407A1 (en) * 2014-11-04 2016-05-12 Bristol-Myers Squibb Company Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
JP7032903B2 (ja) * 2016-10-12 2022-03-09 田辺三菱製薬株式会社 スルホンアミド化合物の製造方法
CN116217571B (zh) * 2023-03-28 2024-11-15 上海锐谱医药科技有限公司 一种制备药物砌块1,2,4-三唑并[4,3-a]吡啶-3-胺的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
IL97726A (en) * 1990-04-10 1994-12-29 Israel Inst Biolog Res Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
BRPI0518949A2 (pt) * 2004-12-15 2008-12-16 Astrazeneca Ab composto, uso de um composto, mÉtodo para induÇço da interrupÇço do hÁbito de fumar, composiÇço farmacÊutica, e, uso de uma composiÇço farmacÊutica
ITMI20061279A1 (it) * 2006-06-30 2008-01-01 Consiglio Nazionale Ricerche Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche
US7863291B2 (en) * 2008-04-23 2011-01-04 Bristol-Myers Squibb Company Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands

Also Published As

Publication number Publication date
NZ600240A (en) 2014-04-30
JP5619907B2 (ja) 2014-11-05
EP2493892B1 (en) 2015-07-01
AU2009354790A1 (en) 2012-06-14
TN2012000191A1 (en) 2013-12-12
EA201270610A1 (ru) 2013-02-28
CA2779177A1 (en) 2011-05-05
IL219366A0 (en) 2012-06-28
JP2013509405A (ja) 2013-03-14
CN102791718A (zh) 2012-11-21
CN102791718B (zh) 2015-11-25
KR20120099060A (ko) 2012-09-06
WO2011053292A1 (en) 2011-05-05
ES2544970T3 (es) 2015-09-07
CA2779177C (en) 2016-08-30
BR112012010054A2 (pt) 2016-05-24
EP2493892A1 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
IL208673A (en) Quinuclidine compounds ligandes for nicotinic alpha-7 acetylcholine receptor
PH12013501758A1 (en) Pyrazolo [1,5-a] pyridines as trk inhibitors
BR112013033182A2 (pt) compostos imidazopiridinil-aminopiridina substituída
IN2014DN07384A (es)
MX2010005648A (es) Derivados de alcano azabiciclico sustituidos con biarilo como moduladores de la actividad del receptor nicotinico de acetilcolina.
MX347917B (es) Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso.
MY174897A (en) Anti-fibrotic pyridinones
WO2009127642A3 (en) Use of lrrk2 inhibitors for neurodegenerative diseases
MX342177B (es) Inhibidores de cinasa 2 de repeticion rica en leucina (lrrk2) macrociclica.
MD20150023A2 (ro) Piridinone biciclice noi
TN2015000018A1 (en) 5-ht3 receptor antagonists
MX368459B (es) Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
WO2014070991A3 (en) Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
MX2010009920A (es) Compuestos de azaindol para tratamiento de trastornos del sistema nervioso central.
TN2012000191A1 (en) Quinuclidine compounds as alpha-7nicotinic acetylcholine receptor ligands
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
TW201613884A (en) Selective NR2B antagonists
IN2012DN03846A (es)
IN2014DN09826A (es)
MX2012004317A (es) Com puestos de azabiciclo[2.2.1] heptano como ligandos de receptor de acetilcolina alfa-7-nicotinico.
MX2012010084A (es) Compuestos utiles para tratar transtornos neurodegenerativos.
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
WO2013048949A3 (en) Selective nr2b antagonists
MX2018004256A (es) Antagonistas de receptor de n-metil-d-aspartato subtipo 2b (nr2b) selectivos.
PH12014502780A1 (en) Azetidine and piperidine compounds useful as pde10 inhibitors

Legal Events

Date Code Title Description
FG Grant or registration